Using Artificial Intelligence (Watson for Oncology) for Treatment Recommendations Amongst Chinese Patients with Lung Cancer: Feasibility Study.

Journal: Journal of medical Internet research
Published Date: Sep 25, 2018

Abstract

BACKGROUND: Artificial intelligence (AI) is developing quickly in the medical field and can benefit both medical staff and patients. The clinical decision support system Watson for Oncology (WFO) is an outstanding representative AI in the medical field, and it can provide to cancer patients prompt treatment recommendations comparable with ones made by expert oncologists. WFO is increasingly being used in China, but limited reports on whether WFO is suitable for Chinese patients, especially patients with lung cancer, exist. Here, we report a retrospective study based on the consistency between the lung cancer treatment recommendations made for the same patient by WFO and by the multidisciplinary team at our center.

Authors

  • Chaoyuan Liu
    Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Xianling Liu
    Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Fang Wu
    Department of Pathology and Laboratory Medicine, St. Paul's Hospital, Saskatchewan Health Authority, Saskatoon, SK, Canada.
  • Mingxuan Xie
    Department of Geriatric Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Yeqian Feng
    Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Chunhong Hu
    Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.

Keywords

External Resources

Popular Topics
Recent Journals